COMMUNIQUÉS West-GlobeNewswire

DBV Technologies présentera des données soutenant l'utilisation de l'immunothérapie épicutanée pour le traitement de l'allergie à l'arachide à l'ACAAI 2018
09/11/2018
Montrouge, France, le 9 novembre (07h30 CEST), 2018 DBV Technologies présentera des données soutenant l'utilisation de l'immunothérapie épicutanée pour le traitement de l'allergie à l'arachide à l'ACAAI 2018 Trois [...]
ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
09/11/2018
Amsterdam, The Netherlands - 09 November 2018 Esperite announces that the preparation of its Annual Report 2017 is nearly finalized and expects the publication of its Annual Report 2017 before 17 November 2018. About [...]
Alligator Bioscience and Aptevo Therapeutics Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
09/11/2018
Data Show That ALG.APV-527 Selectively Activates and Enhances Tumor -directed T-cell and Natural Killer (NK) Cell Responses Targets 5T4 Cancer Antigen Present on Many Types of Solid Tumors LUND, Sweden and SEATTLE, Nov [...]
Intuitive Announces New General Manager in Korea
09/11/2018
SUNNYVALE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq: ISRG), has named Austin Kim as Vice President and General Manager in Korea, where he will direct business strategy and operations [...]
OV - Update Regarding Participation at Investor Events in Q4 2018
09/11/2018
Investor news Hørsholm, Denmark and Cambridge, MA, US, November 5 th , 2018 - Oncology Venture A/S ("Oncology Venture") today provided an update regarding when members of its senior management team are scheduled to make [...]
Sarepta Therapeutics Announces Pricing of $500,000,000 Public Offering of Common Stock
09/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering [...]
Viveve to Present at Stifel 2018 Healthcare Conference
08/11/2018
ENGLEWOOD, Colo., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and [...]
Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]
ADMA Biologics Reports Third Quarter 2018 Financial Results
08/11/2018
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, [...]
Innovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline Priorities
08/11/2018
BEVERLY, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide a corporate update highlighting business [...]
Radient Technologies Inc. Announces AGM Results and Completion of Shares for Debt Transaction
08/11/2018
EDMONTON, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) today announces that all resolutions were passed by the requisite majority at its annual [...]
Extendicare Announces 2018 Third Quarter Results
08/11/2018
MARKHAM, Ontario, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2018. Results are presented in [...]
Mersana Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference
08/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Merus sera présente à la Jefferies 2018 London Healthcare Conference
08/11/2018
UTRECHT, Pays-Bas, 08 nov. 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics®), a [...]
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China
08/11/2018
- 50/50 joint venture with investor syndicate led by Vivo Capital – - Expands global reach for TransCon products – COPENHAGEN, Denmark, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a [...]
Intrommune Therapeutics Announces First Close of Series A Preferred Equity Financing and Successful Close of Crowdfunding Financing Campaign to Support New Peanut Allergy Treatment
08/11/2018
New York, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is pleased to announce [...]
Intellia Therapeutics to Present at November Healthcare Investor Conferences
08/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results
08/11/2018
Company Executing on Lead Programs CPI-1205 and CPI-0610 Expects to Evaluate Proof of Concept for Both Programs in Mid-2019 CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc., ( [...]
Denali Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights and Announces the Appointment of Jennifer Cook to Board of Directors
08/11/2018
SOUTH SAN FRANCISCO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today [...]

Pages